VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $181,705,000 | -84.4% | 1,787,660 | -72.6% | 0.16% | -70.3% |
| Q3 2015 | $1,162,590,000 | +118.5% | 6,517,372 | +172.1% | 0.52% | +19.5% |
| Q2 2015 | $531,995,000 | +7.8% | 2,395,120 | -3.6% | 0.44% | +7.6% |
| Q1 2015 | $493,711,000 | +23.3% | 2,485,396 | -11.1% | 0.41% | +18.4% |
| Q4 2014 | $400,258,000 | +12.2% | 2,796,618 | +2.8% | 0.34% | +5.2% |
| Q3 2014 | $356,752,000 | +20.9% | 2,719,184 | +15.8% | 0.33% | +20.7% |
| Q2 2014 | $294,959,000 | +18.2% | 2,347,582 | +24.1% | 0.27% | +16.4% |
| Q1 2014 | $249,445,000 | -23.6% | 1,892,202 | -32.0% | 0.23% | -24.7% |
| Q4 2013 | $326,610,000 | -4.0% | 2,781,841 | -14.7% | 0.31% | -8.9% |
| Q3 2013 | $340,355,000 | -13.0% | 3,262,001 | -28.2% | 0.34% | -17.2% |
| Q2 2013 | $391,177,000 | – | 4,543,927 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |